Literature DB >> 26629104

MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells.

Ma Isabel Zubillaga-Guerrero1, Luz Del Carmen Alarcón-Romero1, Berenice Illades-Aguiar1, Eugenia Flores-Alfaro1, Víctor Hugo Bermúdez-Morales2, Jessica Deas2, Oscar Peralta-Zaragoza2.   

Abstract

MicroRNAs are involved in diverse biological processes through regulation of gene expression. The microRNA profile has been shown to be altered in cervical cancer (CC). MiR-16-1 belongs to the miR-16 cluster and has been implicated in various aspects of carcinogenesis including cell proliferation and regulation of apoptosis; however, its function and molecular mechanism in CC is not clear. Cyclin E1 (CCNE1) is a positive regulator of the cell cycle that controls the transition of cells from G1 to S phase. In CC, CCNE1 expression is frequently upregulated, and is an indicator for poor outcome in squamous cell carcinomas (SCCs). Thus, in the present brief communication, we determine whether the CCNE1 gene is regulated by miR-16-1 in CC cells. To identify the downstream cellular target genes for upstream miR-16-1, we silenced endogenous miR-16-1 expression in cell lines derived from CC (C-33 A HPV-, CaSki HPV16+, SiHa HPV16+, and HeLa HPV18+ cells), using siRNAs expressed in plasmids. Using a combined bioinformatic analysis and RT-qPCR, we determined that the CCNE1 gene is targeted by miR-16-1 in CC cells. SiHa, CaSki, and HeLa cells demonstrated an inverse correlation between miR-16-1 expression and CCNE1 mRNA level. Thus, miR-16-1 post-transcriptionally down-regulates CCNE1 gene expression. These results, suggest that miR-16-1 plays a vital role in modulating cell cycle processes in CC.

Entities:  

Keywords:  CCNE1; Cervical cancer; HPV; miR-16-1; microRNAs; siRNAs

Year:  2015        PMID: 26629104      PMCID: PMC4658993     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

Review 1.  Regulation of cellular miRNA expression by human papillomaviruses.

Authors:  Zhi-Ming Zheng; Xiaohong Wang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

2.  Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes.

Authors:  N C Popescu; J A DiPaolo; S C Amsbaugh
Journal:  Cytogenet Cell Genet       Date:  1987

3.  MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.

Authors:  Matan Ofir; Dalia Hacohen; Doron Ginsberg
Journal:  Mol Cancer Res       Date:  2011-03-31       Impact factor: 5.852

4.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells.

Authors:  Fu Wang; Xiang-Dong Fu; Yu Zhou; Yi Zhang
Journal:  BMB Rep       Date:  2009-11-30       Impact factor: 4.778

6.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

7.  Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.

Authors:  Tagrid Kaddar; Jean-Pierre Rouault; Wei Wen Chien; Amel Chebel; Mylène Gadoux; Gilles Salles; Martine Ffrench; Jean-Pierre Magaud
Journal:  Biol Cell       Date:  2009-09       Impact factor: 4.458

8.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

9.  Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix.

Authors:  F Erlandsson; H-S Martinsson-Ahlzén; K-L Wallin; A-C Hellström; S Andersson; A Zetterberg
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

10.  Differential expression of genes involved in the epigenetic regulation of cell identity in normal human mammary cell commitment and differentiation.

Authors:  Danila Coradini; Patrizia Boracchi; Saro Oriana; Elia Biganzoli; Federico Ambrogi
Journal:  Chin J Cancer       Date:  2014-09-16
View more
  18 in total

1.  Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a.

Authors:  Shaofeng Mou; Zhongxin Zhou; Yukai He; Fuxing Liu; Lili Gong
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

Review 2.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

3.  MicroRNA-874-mediated inhibition of the major G1/S phase cyclin, CCNE1, is lost in osteosarcomas.

Authors:  Tanushree Ghosh; Akhil Varshney; Praveen Kumar; Manpreet Kaur; Vipin Kumar; Ritu Shekhar; Raksha Devi; Priyanka Priyanka; Md Muntaz Khan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

4.  Tumor suppressor function of miR-483-3p on breast cancer via targeting of the cyclin E1 gene.

Authors:  Xiaoxi Huang; Jin Lyu
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

5.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

6.  Downregulation of miR-16 via URGCP pathway contributes to glioma growth.

Authors:  Liang Hong; Ouyang Qing; Zhou Ji; Zhang Chengqu; Chen Ying; Cui Hao; Xu Minhui; Xu Lunshan
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

7.  Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.

Authors:  Alboukadel Kassambara; Michel Jourdan; Angélique Bruyer; Nicolas Robert; Véronique Pantesco; Olivier Elemento; Bernard Klein; Jérôme Moreaux
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

Review 8.  Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.

Authors:  Angelica Judith Granados-López; José Luis Ruiz-Carrillo; Luis Steven Servín-González; José Luis Martínez-Rodríguez; Claudia Araceli Reyes-Estrada; Rosalinda Gutiérrez-Hernández; Jesús Adrián López
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

Review 9.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

10.  Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro.

Authors:  Liping Sun; Dong Li; Kun Song; Jianlu Wei; Shu Yao; Zhao Li; Xuantao Su; Xiuli Ju; Lan Chao; Xiaohui Deng; Beihua Kong; Li Li
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.